OBJECTIVE: To determine if increasing nitric oxide bioactivity by inclusion of ethyl nitrite (ENO) in the insufflation admixture would attenuate pneumoperitoneum-induced decreases in splanchnic perfusion. SUMMARY BACKGROUND DATA: Organ blood flow is reduced during pneumoperitoneum and can contribute to laparoscopy-associated morbidity and mortality. Previous attempts to control such decreases in flow have been ineffective. METHODS: Laser-Doppler flow probes were placed on the liver and right kidney of anesthetized pigs. After a baseline recording period, animals were insufflated to a final intraperitoneal pressure of 15 mm Hg. Group one received CO2 (standard practice), whereas group 2 received CO2 plus 100 ppm ENO. Insufflation was maintained for 60 minutes and then the abdomen was manually deflated; monitoring was continued for another 60 minutes. RESULTS: CO2 insufflation (n = 5) cut liver blood flow in half; liver flow remained at this level throughout the postinsufflation period. Inclusion of 100 ppm ENO (n = 6) attenuated both the acute and prolonged blood flow decreases. Statistical modeling of the data showed that, on average, liver blood flow was 14.3 U/min higher in the ENO pigs compared with the CO2 group (P = 0.0454). In contrast, neither treatment significantly altered kidney blood flow (P = 0.6215). CONCLUSION: The data indicate that ENO can effectively attenuate pneumoperitoneum-induced blood flow decreases within the peritoneal cavity. The result suggests a novel therapeutic method of regulating hemodynamic changes during laparoscopic procedures.
OBJECTIVE: To determine if increasing nitric oxide bioactivity by inclusion of ethyl nitrite (ENO) in the insufflation admixture would attenuate pneumoperitoneum-induced decreases in splanchnic perfusion. SUMMARY BACKGROUND DATA: Organ blood flow is reduced during pneumoperitoneum and can contribute to laparoscopy-associated morbidity and mortality. Previous attempts to control such decreases in flow have been ineffective. METHODS: Laser-Doppler flow probes were placed on the liver and right kidney of anesthetized pigs. After a baseline recording period, animals were insufflated to a final intraperitoneal pressure of 15 mm Hg. Group one received CO2 (standard practice), whereas group 2 received CO2 plus 100 ppm ENO. Insufflation was maintained for 60 minutes and then the abdomen was manually deflated; monitoring was continued for another 60 minutes. RESULTS:CO2 insufflation (n = 5) cut liver blood flow in half; liver flow remained at this level throughout the postinsufflation period. Inclusion of 100 ppm ENO (n = 6) attenuated both the acute and prolonged blood flow decreases. Statistical modeling of the data showed that, on average, liver blood flow was 14.3 U/min higher in the ENO pigs compared with the CO2 group (P = 0.0454). In contrast, neither treatment significantly altered kidney blood flow (P = 0.6215). CONCLUSION: The data indicate that ENO can effectively attenuate pneumoperitoneum-induced blood flow decreases within the peritoneal cavity. The result suggests a novel therapeutic method of regulating hemodynamic changes during laparoscopic procedures.
Authors: M P Moya; A J Gow; T J McMahon; E J Toone; I M Cheifetz; R N Goldberg; J S Stamler Journal: Proc Natl Acad Sci U S A Date: 2001-04-24 Impact factor: 11.205
Authors: M Agustí; J I Elizalde; R Adàlia; G Martínez-Pallí; J C García-Valdecasas; J M Piqué; P Taurà Journal: Anesth Analg Date: 2001-11 Impact factor: 5.108
Authors: G K Glantzounis; A D Tselepis; A P Tambaki; T A Trikalinos; A D Manataki; D A Galaris; E C Tsimoyiannis; A M Kappas Journal: Surg Endosc Date: 2001-08-16 Impact factor: 4.584
Authors: Kazufumi Shimazutsu; Kenichiro Uemura; Kathryn M Auten; Matthew F Baldwin; Samuel W Belknap; Francisco La Banca; Maximilian C Jones; Deborah J McClaine; Rebecca J McClaine; W Steve Eubanks; Jonathan S Stamler; James D Reynolds Journal: Clin Transl Sci Date: 2009-12 Impact factor: 4.689
Authors: James D Reynolds; Trevor Jenkins; Faisal Matto; Ryan Nazemian; Obada Farhan; Nathan Morris; John M Longphre; Douglas T Hess; Richard E Moon; Claude A Piantadosi; Jonathan S Stamler Journal: Clin Pharmacol Ther Date: 2018-01-17 Impact factor: 6.875
Authors: J F Kuebler; N Schukfeh; G Vieten; W A Osthaus; D Huber; N Dennhard; R Suempelmann; B M Ure; M L Metzelder Journal: Surg Endosc Date: 2017-12-27 Impact factor: 4.584
Authors: Chris Westgarth-Taylor; Leonnie de Lijster; Guido van Bogerijen; Alastair J W Millar; Jonathan Karpelowsky Journal: Surg Endosc Date: 2013-04-19 Impact factor: 4.584
Authors: N Alexakis; H Gakiopoulou; C Dimitriou; K Albanopoulos; A Fingerhut; M Skalistira; E Patsouris; J Bramis; E Leandros Journal: Surg Endosc Date: 2008-02 Impact factor: 4.584